{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:36:21Z","timestamp":1790750181312,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011440","name":"Zhejiang Provincial Key Laboratory of Wood Science and Technology","doi-asserted-by":"crossref","award":["2011R50015"],"award-info":[{"award-number":["2011R50015"]}],"id":[{"id":"10.13039\/501100011440","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572920"],"award-info":[{"award-number":["81572920"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China (973 Program)","doi-asserted-by":"crossref","award":["2013CB911303"],"award-info":[{"award-number":["2013CB911303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Zhejiang Province of China","award":["LY15H160038"],"award-info":[{"award-number":["LY15H160038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00277-019-03821-9","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T12:02:56Z","timestamp":1574424176000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-6171","authenticated-orcid":false,"given":"Xiang-Gui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Ran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"issue":"suppl 5","key":"3821_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"T. A. Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology 14(Suppl 5):v1\u2013v49. https:\/\/doi.org\/10.1093\/neuonc\/nos218","journal-title":"Neuro-Oncology"},{"issue":"12","key":"3821_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11912-015-0483-8","volume":"17","author":"LB Patrick","year":"2015","unstructured":"Patrick LB, Mohile NA (2015) Advances in primary central nervous system lymphoma. Curr Oncol Rep 17(12):60. https:\/\/doi.org\/10.1007\/s11912-015-0483-8","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"3821_CR3","first-page":"281","volume":"7","author":"A Ruiz","year":"1997","unstructured":"Ruiz A, Post JD, Bundschu C, Ganz WI, Georgiou M (1997) Primary central nervous system lymphoma in patients with AIDS. Neuroimaging Clin N Am 7(2):281","journal-title":"Neuroimaging Clin N Am"},{"issue":"3","key":"3821_CR4","first-page":"463","volume":"46","author":"TG Phan","year":"1999","unstructured":"Phan TG, O\u2019Neill BP, Habermann TM (1999) Post-transplant primary central nervous system lymphoma. Ann Neurol 46(3):463\u2013463","journal-title":"Ann Neurol"},{"issue":"2","key":"3821_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","volume":"92","author":"B Bataille","year":"2000","unstructured":"Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92(2):261\u2013266. https:\/\/doi.org\/10.3171\/jns.2000.92.2.0261","journal-title":"J Neurosurg"},{"issue":"3","key":"3821_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1440-1789.2009.01074.x","volume":"30","author":"D Raoux","year":"2010","unstructured":"Raoux D, Duband S, Forest F, Trombert B, Chambonniere ML, Dumollard JM, Khaddage A, Gentil-Perret A, Peoc\u2019h M (2010) Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance. Neuropathology 30(3):232\u2013240. https:\/\/doi.org\/10.1111\/j.1440-1789.2009.01074.x","journal-title":"Neuropathology"},{"issue":"5","key":"3821_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1634\/theoncologist.2008-0236","volume":"14","author":"M Sierra del Rio","year":"2009","unstructured":"Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K (2009) Primary CNS lymphoma in immunocompetent patients. Oncologist 14(5):526\u2013539. https:\/\/doi.org\/10.1634\/theoncologist.2008-0236","journal-title":"Oncologist"},{"issue":"1","key":"3821_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan ZG, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"issue":"3","key":"3821_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11060-010-0269-7","volume":"101","author":"AD Norden","year":"2011","unstructured":"Norden AD, Drappatz J, Wen PY, Claus EB (2011) Survival among patients with primary central nervous system lymphoma, 1973-2004. J Neuro-Oncol 101(3):487\u2013493. https:\/\/doi.org\/10.1007\/s11060-010-0269-7","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"3821_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau C, Dell\u2019Oro S, Zucca E, Cavalli F (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 21(2):266\u2013272. https:\/\/doi.org\/10.1200\/JCO.2003.09.139","journal-title":"J Clin Oncol"},{"issue":"2","key":"3821_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2003.11.001","volume":"59","author":"EM Bessell","year":"2004","unstructured":"Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J (2004) Primary non-Hodgkin\u2019s lymphoma of the CNS treated with CHOD\/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Int J Radiat Oncol Biol Phys 59(2):501\u2013508. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.11.001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"36","key":"3821_CR12","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1200\/JCO.2006.08.2941","volume":"24","author":"LE Abrey","year":"2006","unstructured":"Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24(36):5711\u20135715. https:\/\/doi.org\/10.1200\/JCO.2006.08.2941","journal-title":"J Clin Oncol"},{"key":"3821_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2016.01.016","volume":"57","author":"JE Jang","year":"2016","unstructured":"Jang JE, Kim YR, Kim SJ, Cho H, Chung H, Lee JY, Park H, Kim Y, Cheong JW, Min YH, Kim JS (2016) A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma. Eur J Cancer 57:127\u2013135. https:\/\/doi.org\/10.1016\/j.ejca.2016.01.016","journal-title":"Eur J Cancer"},{"issue":"6","key":"3821_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/00313025.2010.508786","volume":"42","author":"M Preusser","year":"2010","unstructured":"Preusser M, Woehrer A, Koperek O, Rottenfusser A, Dieckmann K, Gatterbauer B, Roessler K, Slavc I, Jaeger U, Streubel B, Hainfellner JA, Chott A (2010) Primary central nervous system lymphoma: a clinicopathological study of 75 cases. Pathology 42(6):547\u2013552. https:\/\/doi.org\/10.3109\/00313025.2010.508786","journal-title":"Pathology"},{"issue":"4","key":"3821_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12185-014-1540-z","volume":"99","author":"S Dalia","year":"2014","unstructured":"Dalia S, Forsyth P, Chavez J, Price S, Shah B, Bello C, Sokol L, Pan E, Sotomayor E, Lee JH, Fisher K, Jaglal M (2014) Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center. Int J Hematol 99(4):450\u2013456. https:\/\/doi.org\/10.1007\/s12185-014-1540-z","journal-title":"Int J Hematol"},{"issue":"10","key":"3821_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1212\/01.WNL.0000034256.20173.EA","volume":"59","author":"R Lai","year":"2002","unstructured":"Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59(10):1557\u20131562","journal-title":"Neurology"},{"issue":"1","key":"3821_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejso.2004.10.002","volume":"31","author":"M Bellinzona","year":"2005","unstructured":"Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Ejso 31(1):100\u2013105. https:\/\/doi.org\/10.1016\/j.ejso.2004.10.002","journal-title":"Ejso"},{"issue":"12","key":"3821_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/neuonc\/nos159","volume":"14","author":"M Weller","year":"2012","unstructured":"Weller M, Martus P, Roth P, Thiel E, Korfel A (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro-Oncology 14(12):1481\u20131484. https:\/\/doi.org\/10.1093\/neuonc\/nos159","journal-title":"Neuro-Oncology"},{"key":"3821_CR19","doi-asserted-by":"publisher","first-page":"e1436","DOI":"10.1016\/j.wneu.2019.02.252","volume":"126","author":"Collin M. Labak","year":"2019","unstructured":"Labak CM, Holdhoff M, Bettegowda C, Gallia GL, Lim M, Weingart JD, Mukherjee D (2019) Surgical resection for primary central nervous system lymphoma: a systematic review. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2019.02.252","journal-title":"World Neurosurgery"},{"issue":"1","key":"3821_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-016-2358-8","volume":"132","author":"Michael Brendan Cloney","year":"2017","unstructured":"Cloney MB, Sonabend AM, Yun J, Yang J, Iwamoto F, Singh S, Bhagat G, Canoll P, Zanazzi G, Bruce JN, Sisti M, Sheth S, Connolly ES, McKhann G (2017) The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis. J Neuro-Oncol 132(1):189\u2013197. https:\/\/doi.org\/10.1007\/s11060-016-2358-8","journal-title":"Journal of Neuro-Oncology"},{"key":"3821_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/Fneur.2017.00478","volume":"8","author":"J Yun","year":"2017","unstructured":"Yun J, Yang JY, Cloney M, Mehta A, Singh S, Iwamoto FM, Neugut AI, Sonabend AM (2017) Assessing the safety of craniotomy for resection of primary central nervous system lymphoma: a nationwide inpatient sample analysis. Front Neurol 8:478. https:\/\/doi.org\/10.3389\/Fneur.2017.00478","journal-title":"Front Neurol"},{"issue":"4","key":"3821_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/1078-0432.CCR-05-1699","volume":"12","author":"CH Lin","year":"2006","unstructured":"Lin CH, Ku KT, Chuang SS, Kuo SH, Chang JH, Chang KC, Hsu HC, Tien HF, Cheng AL (2006) Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin Cancer Res 12(4):1152\u20131156. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1699","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3821_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","volume":"52","author":"Laura Pasqualucci","year":"2015","unstructured":"Pasqualucci L, Dalla-Favera R (2015) The genetic landscape of diffuse large B-cell lymphoma. Semin Hematol 52(2):67\u201376. https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.005","journal-title":"Seminars in Hematology"},{"issue":"1","key":"3821_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/cncr.23149","volume":"112","author":"O Levy","year":"2008","unstructured":"Levy O, DeAngelis LM, Filippa DA, Panageas KS, Abrey LE (2008) Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 112(1):151\u2013156. https:\/\/doi.org\/10.1002\/cncr.23149","journal-title":"Cancer"},{"issue":"5","key":"3821_CR25","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.3892\/ol.2017.6893","volume":"14","author":"J Liu","year":"2017","unstructured":"Liu J, Wang YM, Liu YT, Liu Z, Cui Q, Ji N, Sun SJ, Wang BX, Wang YJ, Sun XF, Liu YB (2017) Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases. Oncol Lett 14(5):5505\u20135512. https:\/\/doi.org\/10.3892\/ol.2017.6893","journal-title":"Oncol Lett"},{"issue":"9700","key":"3821_CR26","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0140-6736(09)61416-1","volume":"374","author":"AJM Ferreri","year":"2009","unstructured":"Ferreri AJM, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F, Ielsg (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374(9700):1512\u20131520. https:\/\/doi.org\/10.1016\/S0140-6736(09)61416-1","journal-title":"Lancet"},{"issue":"5","key":"3821_CR27","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S2352-3026(16)00036-3","volume":"3","author":"Andr\u00e9s J M Ferreri","year":"2016","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, La Rosee P, Schorb E, Ambrosetti A, Roth A, Hemmoway C, Ferrari A, Linton KM, Ruda R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gorlov JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Covalli F, Finke J, Reni M, Zucca E, Illerhaus G, Ielsg (2016) Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 3(5):E217\u2013E227. https:\/\/doi.org\/10.1016\/S2352-3026(16)00036-3","journal-title":"The Lancet Haematology"},{"issue":"11","key":"3821_CR28","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"AJM Ferreri","year":"2017","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosee P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Gorlov JS, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G, Ielsg (2017) Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol 4(11):E510\u2013E523. https:\/\/doi.org\/10.1016\/S2352-3026(17)30174-6","journal-title":"Lancet Haematol"},{"issue":"1","key":"3821_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","volume":"23","author":"DF Nelson","year":"1992","unstructured":"Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin\u2019s lymphoma of the brain: can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation. Therapy Oncology Group (RTOG): RTOG 8315 Int J Radiat Oncol 23(1):9\u201317. https:\/\/doi.org\/10.1016\/0360-3016(92)90538-S","journal-title":"Therapy Oncology Group (RTOG): RTOG 8315 Int J Radiat Oncol"},{"issue":"3","key":"3821_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijrpbp.2004.12.043","volume":"62","author":"Y Shibamoto","year":"2005","unstructured":"Shibamoto Y, Ogino H, Hasegawa M, Suzuki K, Nishio M, Fujii T, Kato E, Ishihara SI, Sougawa M, Kenjo M, Kawamura T, Hayabuchi N (2005) Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Int J Radiat Oncol 62(3):809\u2013813. https:\/\/doi.org\/10.1016\/j.ijrpbp.2004.12.043","journal-title":"Int J Radiat Oncol"},{"issue":"11","key":"3821_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","volume":"11","author":"Eckhard Thiel","year":"2010","unstructured":"Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Roth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithauser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nagele T, Pietsch T, Bamberg M, Weller M (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11(11):1036\u20131047. https:\/\/doi.org\/10.1016\/S1470-2045(10)70229-1","journal-title":"The Lancet Oncology"},{"issue":"6","key":"3821_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/Cco.0000000000000403","volume":"29","author":"K Benekou","year":"2017","unstructured":"Benekou K, Montoto S (2017) Role of stem cell transplant in lymphoma in the era of new drugs. Curr Opin Oncol 29(6):455\u2013459. https:\/\/doi.org\/10.1097\/Cco.0000000000000403","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"3821_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/hon.2021","volume":"31","author":"Herv\u00e9 Ghesqui\u00e8res","year":"2012","unstructured":"Ghesquieres H, Drouet Y, Sunyach MP, Sebban C, Chassagne-Clement C, Jouanneau E, Honnorat J, Biron P, Blay JY (2013) Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients. Hematol Oncol 31(2):57\u201364. https:\/\/doi.org\/10.1002\/hon.2021","journal-title":"Hematological Oncology"},{"issue":"4","key":"3821_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/neuonc\/nop053","volume":"12","author":"P Kiewe","year":"2010","unstructured":"Kiewe P, Fischer L, Martus P, Thiel E, Korfel A (2010) Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort. Neuro-Oncology 12(4):409\u2013417. https:\/\/doi.org\/10.1093\/neuonc\/nop053","journal-title":"Neuro-Oncology"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03821-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:37:06Z","timestamp":1605919026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03821-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03821-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Human Ethics Committee of the Second Affiliated Hospital, School of Medicine, Zhejiang University, China.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"An informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}